Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Sulfation is a major modification of many molecules in eukaryotes that is dependent on the enzymatic synthesis of an activated sulfate donor, 3'‐phosphoadenosine 5'‐phosphosulfate (PAPS). While sulfate activation has long been assumed to occur in the cytosol, we show in this study that human PAPS synthetase 1 (PAPSS1), a bifunctional ATP sulfurylase/adenosine 5'‐phosphosulfate (APS) kinase enzyme sufficient for PAPS synthesis, accumulates in the nucleus of mammalian cells. Nuclear targeting of the enzyme is mediated by its APS kinase domain and requires a catalytically dispensable 21 amino acid sequence at the amino terminus. Human PAPSS1 and Drosophila melanogaster PAPSS localize to the nucleus in yeast and relieve the methionine auxotrophy of ATP sulfurylase‐ or APS kinase‐deficient strains, suggesting that PAPSS1 is fully functional in vivo when targeted to the nucleus. A second PAPS synthetase gene, designated PAPSS2 , has recently been described, mutations of which are responsible for abnormal skeletal development in human spondyloepimetaphyseal dysplasia and murine brachymorphism. We found that PAPSS2, which localizes to the cytoplasm when ectopically expressed in mammalian cells, is relocated to the nucleus when coexpressed with PAPSS1. Taken together, these results indicate that a sulfation pathway might exist in the nucleus of eukaryotic cells.—Besset, S., Vincourt, J.‐B., Amalric, F., Girard, J.‐P. Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells. FASEB J. 14, 345–354 (2000)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolism of sulfur amino acids in Saccharomyces cerevisiae.
Thomas, D., & Surdin-Kerjan, Y. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.4.503-532.1997 · Cited by 678 · cited 2×
“Due to the lack of availability of activated sulfate for PAPS reductase, met3 and met14 mutants are unable to synthesize sulfur-containing amino acids (23) and thus require the activity of an ectopically expressed enzyme (ATP sulfurylase, APS kinase, or PAPS synthetase) to complement their methionine auxotrophy.”
BackgroundEnzymology of human cytosolic sulfotransferases
Falany, C. N. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.4.9068609 · Cited by 604 · cited 1×
“Indeed, cytosol and Golgi apparatus are the only sites of PAPS utilization by known sulfotransferases (11, 12, 16).”
BackgroundIntroduction: Changing view of sulfation and the cytosolic sulfotransferases
Falany, C. N. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034159 · Cited by 80 · cited 2×
“by sulfotransferases (1), and in lower organisms for”
Background
Cited by
Aquaporins in the Kidney: From Molecules to Medicine
Nielsen, S., Frøkiær, J., Marples, D., Kwon, T.-H., Agre, P., & Knepper, M. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00024.2001 · Cited by 1,251
Sulfonation and molecular action
Strott, C. A. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0040 · Cited by 487
Inactivating PAPSS2 Mutations in a Patient with Premature Pubarche
Noordam, C., Dhir, V., McNelis, J. C., Schlereth, F., Hanley, N. A., Krone, N., Smeitink, J. A., Smeets, R., Sweep, F. C. G. J., Grinten, H. L. C.-V. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810489 · Cited by 169
Pharmacogenetics of human cytosolic sulfotransferases
Nowell, S., & Falany, C. N. (2006) · Oncogene · doi:10.1038/sj.onc.1209376 · Cited by 158
“The pattern of expression of these isoforms differ according to the tissue examined and it has been shown that subcellular localization can depend on coexpression of the two isoforms (Besset et al., 2000).”
Background
Metadata
- Authors
- Besset, S., Vincourt, J.-B., Amalric, F., & Girard, J.-P.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-02
- Volume
- 14
- Issue
- 2
- Pages
- 345-354
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1603236469
- Cited by
- 63
- References
- 3
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.